Protein arginine deiminase 4: a target for an epigenetic cancer therapy

Overview of attention for article published in Cellular and Molecular Life Sciences, August 2010

Altmetric Badge

Mentioned by

patent: 13 patents

Citations

dimensions_citation: 100 Dimensions

Readers on

mendeley: 69 Mendeley

So far, Altmetric has seen 13 patents that reference this research output.

Protein arginine deiminase 4: a target for an epigenetic cancer therapy

Mentioned by

Citations

Readers on

Heteroaryl inhibitors of PAD4

Grant US-11897866-B2

United States of America

Heterocyclic compounds as pad inhibitors

Grant US-11833156-B2

United States of America

Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation

Grant US-11629135-B2

United States of America

Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation

Grant US-11529341-B2

United States of America

Heterocyclic compounds as PRMT5 inhibitors

Grant US-11459338-B2

United States of America

Heteroaryl inhibitors of PAD4

Grant US-11198681-B2

United States of America

Heteroaryl inhibitors of PAD4

Grant US-11026937-B2

United States of America

Benzoimidazole derivatives as PAD4 inhibitors

Grant US-10815218-B2

United States of America

Covalent inhibitors of PAD4

Grant US-10703741-B2

United States of America

Benzoimidazole derivatives as PAD4 inhibitors

Grant US-10407407-B2

United States of America

Treatment of sepsis and septic shock

Application US-10131707-B2

United States of America

Bicyclic inhibitors of PAD4

Application US-9963448-B2

United States of America

Aza-benzimidazole inhibitors of PAD4

Application US-9765093-B2

United States of America